Callan Family Office’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$237K Buy
2,548
+26
+1% +$2.3K 0.01% 1002
2025
Q4
$203K Buy
+2,522
New +$211K ﹤0.01% 1054

Other funds holding ACLS

Callan Family Office's ACLS Position: Q1 2026 in Review

Callan Family Office increased its Axcelis (ACLS) stake by 1% in Q1 2026, buying an estimated $2.3K and bringing the position to 2,548 shares worth $237K. The position accounts for 0.01% of the portfolio, ranked #1002.

Callan Family Office first reported a position in ACLS in Q4 2025 and has held it in 2 quarters since. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Callan Family Office held 2,548 shares of Axcelis worth $237K as of Q1 2026.
  • Callan Family Office bought 26 Axcelis shares in Q1 2026, an estimated $2.3K.
  • Axcelis made up 0.01% of Callan Family Office's portfolio in Q1 2026, its #1002 holding.
  • Callan Family Office first reported a position in Axcelis in Q4 2025 and has held it in 2 quarters since.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.